Digital pathology is a dynamic and image-based
environment technology, which enables the management, acquisition, and
interpretation of pathology information generated from a digitized glass slide.
It converts glass slides into digital slides that can be observed, managed,
shared or examined on a computer monitor. The key benefits are included better
efficiency, quicker & increasingly effective work process, portability
& durability, better results for patients, cutting costs etc.
According to study, “Global
Digital Pathology Market Research Report, by Type (Human Pathology,
Animal Pathology), Product (Hardware, Software), Application (Disease
Diagnosis, Mhealth, Drug Discovery) and End-Users (Hospitals, Diagnostic
Centers) - Global Forecast Till 2023” the key companies operating in the global
digital pathology market are Koninklijke Philips N.V., Inspirata, Olympus
Corporation of the Americas, 3DHISTECH Ltd., Huron Digital Pathology Inc.,
Definiens, F. Hoffmann-La Roche Ltd, Danaher Corporation (Leica Biosystems
GmbH), Mikroscan Technologies, Inc., micro dimensions GmbH. The key players are
focused on receiving regulatory approvals for new products to boost their
market share, which in turn is anticipated to boost the market growth.
Based on type, digital pathology market is
segmented into veterinary pathology and human pathology. Human pathology
segment dominates the market owing to rise in number of collaborations between
pathology laboratories, academic institutes & universities and increase in
utilization of digital systems. Based on product type, market is segmented into
scanner, software, communication systems, and storage systems. Software product
segment is estimated to observe notable growth, as these products are
user-friendly and feature analytical & advanced functions for diagnosis
purposes. Based on technology, market is segmented into whole slide imaging,
static telepathology, telepathology and dynamic telepathology. Based on
application, market is segmented into disease diagnosis, drug discovery, teleconsultation,
and training & education. The telecnsultation segment is expected to
witness considerable growth due to growth in demand for quality healthcare and
rise in diagnosis of diseases during the forecast period. In addition, based on
application, market is segmented into pharmaceutical & biotechnology
companies, academic institutes & research laboratories and hospitals &
clinics.
The digital pathology market is driven by
increase in spending on the healthcare & IT sector, followed by rise in prevalence
of chronic diseases, surge in diagnosis in remote regions, rise in availability
of funds for research, increase in geriatric population, ease of consultation
and rise in applications of radiology information systems. However, lack of
skilled radiology professionals, high cost of software and security concerns
may impact the market. Moreover, increase in potential of digital pathology is
a key opportunity for market. Furthermore, integration of artificial
intelligence (AI) technologies is a major trend for market.
Based on geography, the North-American region
dominates the digital pathology market owing to well-developed healthcare
sector, presence of some of the matured market players and high per capita
healthcare expenditures in the region. The Asian-Pacific region is estimated to
witness higher growth rate due to huge patient population and favorable
government policies over the forecast period. It is anticipated that future of
the market will be bright because of rise in government support for research
& development (R&D) activities during the forecast period. The global
market is projected to reach a market value of US $8,305.6 million by 2023 from
US $3,937 million in 2017 and is projected to register a CAGR of 13.04%
throughout the forecast period from 2018 to 2023.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249